Spinal cord glia: New players in pain

Pain

Volumn 93, Issue 3, 2001, Pages 201-205

  Watkins, Linda R ^a   Milligan, Erin D ^a   Maier, Steven F ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PENTOXIFYLLINE; PROPENTOFYLLINE; SEMAPIMOD; THALIDOMIDE DERIVATIVE; XANTHINE DERIVATIVE;

ASTROCYTE; CELL ACTIVATION; CELL INTERACTION; DRUG EFFECT; HUMAN; MEDIATOR RELEASE; MICROGLIA; NEUROMODULATION; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN; PRIORITY JOURNAL; REVIEW; SPINAL CORD;

ANIMALS; HUMANS; NEUROGLIA; PAIN; SPINAL CORD;

EID: 0034882399     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(01)00359-1     Document Type: Review

References (34)

1. Central neuron-glial and glial-glial interactions following axon injury
2. Phase I study of CNI-1493, an inhibitor of cytokine release, in combination with high dose interleukin-2, in patients with renal cancer and melanoma
3. Priming effect of morphine on the production of tumor necrosis factor-alpha by microglia: Implications in respiratory burst activity and human immunodeficiency virus-1 expression
4. Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage
5. Proinflammatory cytokines and glial cells: Their role in neuropathic pain
6. Mycoplasma fermentans-induced inflammatory response of astrocytes: Selective modulation by aminoguanidine, thalidomide, pentoxifylline and IL-10
7. Glia: Listening and talking to the synapse
8. Extracellular ATP. Triggers tumor necrosis factor-alpha release from rat microglia
9. Interleukin-1beta induces substance P release from primary afferent neurons through the cyclooxygenase-2 system
10. Does the right side know what the left is doing?
11. Microglia: A sensor for pathological events in the CNS
12. Glial fibrillary acidic protein: Regulation by hormones, cytokines and growth factors
13. Inhibition of p38MAP kinase as a therapeutic strategy
14. Effect of interleukin-1beta on the release of substance P from rat isolated spinal cord
15. Delayed-type hypersensitivity lesions in the central nervous system are prevented by inhibitors of matrix metalloproteinases
16. The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat
17. Propentofylline in the treatment of vascular dementia and Alzheimer-type dementia: Overview of phase I and phase II clinical trials
18. Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the Human Immunodeficiency Virus-1 (HIV-1) envelope glycoprotein, gp120
19. Systemic administration of CNI-1493, a p38 MAP kinase inhibitor, blocks HIV-1 gp120-induced enhanced pain states in rats
20. Intrathecal HIV-1 envelope glycoprotein gp120 enhanced pain states mediated by spinal cord proinflammatory cytokines
21. Cholecystokinin activates CCKB-receptor-mediated Ca-signaling in hippocampal astrocytes
22. Brain cytokines and pain
23. Antitumor necrosis factor therapy for inflammatory bowel disease: A review of agents, pharmacology, clinical results, and safety
24. The involvement of glial cells in the development of morphine tolerance
25. Propentofylline, a glial modulating agent, exhibits anti-allodynic properties in a rat model of neuropathic pain
26. Role of Na(+)-Ca2 + exchanger in agonist-induced Ca2 + signaling in cultured rat astrocytes
27. Abdominal pain in HIV infection
28. Spinal fractalkine induces allodynia and hyperalgesia
29. Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat
30. Dynamic regulation of the proinflammatory cytokine, interleukin-1 beta: Molecular biology for non-molecular biologists
31. Glial activation: A driving force for pathological pain
32. Glial proinflammatory cytokines mediate exaggerated pain states: Implications for clinical pain